MFDS Human Cell Management Business Certification: EHL BIO's Gold Standard for Safety

Quick answer

The Human Cell Management Business certification by the Korean Ministry of Food and Drug Safety (MFDS) is the highest regulatory standard under the Advanced Regenerative Bio Act, with EHL BIO being the first in Korea to achieve this. It covers the entire process of cell collection, inspection, and processing to ensure maximum quality and safety according to the EHL team's assessment.

Key takeaways

EHL BIO is the first company in Korea to be certified as a Human Cell Management Business by the MFDS.
The certification falls under the Advanced Regenerative Bio Act, regulated by relevant authorities in Korea.
It covers standards for managing stem cells and immune cells at every stage, from collection to recovery use.
EHL BIO's hospitals and research centers operate under GMP standards at Class 100 cleanliness levels.

The Significance of Human Cell Management Certification

In the biotechnology industry, safety is the ultimate priority. EHL BIO was officially approved by the Ministry of Food and Drug Safety (MFDS) as a Human Cell Management Business on January 11, 2021. This marks a critical step under the 'Advanced Regenerative Medicine and Advanced Biopharmaceuticals Act' to elevate safety standards and quality control in the collection, testing, and processing of stem cells and immune cells to the highest level.

Being the first in Korea to receive this approval ensures that cell management within the organization is systematic and transparent. Clients can rest assured that cells cultured and stored at the EHL Cell Center are handled under the strictest regulations, maintaining optimal cell efficacy according to the EHL team's assessment before being used for actual recovery.

GMP Standards and Production Innovation

The core reason EHL BIO received this certification lies in its high-standard GMP (Good Manufacturing Practices) facilities. We operate Class 100 Clean Rooms equipped with high-efficiency HEPA filters and modern equipment like Biological Safety Cabinets (BSC) for biosafety. Our comprehensive cell storage system utilizes liquid nitrogen tanks to maintain cells at -196 degrees Celsius.

With a production capacity of up to 6,000 lots per year and a specialized research team of over 85 people, EHL BIO maintains excellent cell survival rates and significantly higher cell yields than general standards, reinforcing its leadership in delivering advanced and safe medical technologies.

EHL BIO is the first in Korea approved as a Human Cell Management Business, aiming for the best recovery goals and quality of life.

Service Protocol and Support by EHL Thailand

To ensure Thai citizens have convenient access to this innovation, EHL Thailand provides a Thai-speaking coordination team to support every step. The process begins with submitting a consultation via the website, where EHL BIO's expert physicians directly evaluate medical records. Subsequently, the team assists in travel planning and scheduling for physical exams and cell collection at the EHL Cell Center in Apgujeong, Seoul.

Once the cultivation process in the GMP laboratory is complete and passes rigorous quality checks, clients receive personalized recovery plans under the close supervision of Korean medical teams. After completing the procedure and returning to Thailand, the EHL Thailand team continues to monitor results and coordinate with the Korean headquarters to ensure recovery goals and quality of life are met.

Future of Recovery and Quality of Life under Certified Standards

MFDS certification is more than just a license; it is a testament to EHL BIO's commitment to enhancing quality of life. Currently, we are developing several products in the medical development stage, such as ADSTEM for skin conditions and KDSTEM from urine-derived stem cells for chronic kidney concerns, which has received Phase 1 IND approval.

Collaborations with leading university hospitals in Korea reinforce that EHL BIO's certified standards are widely recognized. We strive to utilize innovative cell therapy and exosomes to create a better quality of life for clients in areas such as neuro-regeneration, osteoarthritis, immune systems, and anti-aging, ensuring sustainable health according to the EHL team's assessment.

Frequently asked questions

What are the recovery goals and quality of life standards under MFDS certification?

The primary goal is to enhance quality of life through cell management processes that meet Korean legal safety standards, reducing contamination risks and controlling cell efficacy according to the EHL team's assessment.

What is the importance of EHL BIO's GMP Class 100 standard?

It refers to the cleanliness level of the cell culture laboratory, where particles are strictly controlled to ensure that stem cells and immune cells are highly pure and not negative for the client.

How can Thai people access services at the EHL Cell Center?

You can contact EHL Thailand to submit information for initial evaluation by doctors in Korea. The team will handle scheduling and provide comprehensive travel planning to Korea.